Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance-Reference-Cited by-同舟云学术

Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance

Published:2018-08-06 Issue:9 Volume:3 Page:1032-1042
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Hicks Nathan D.,Yang Jian^ORCID,Zhang Xiaobing,Zhao Bing,Grad Yonatan H.^ORCID,Liu Liguo,Ou Xichao,Chang Zhili,Xia Hui,Zhou Yang,Wang Shengfen,Dong Jie,Sun Lilian,Zhu Yafang,Zhao Yanlin^ORCID,Jin Qi^ORCID,Fortune Sarah M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

http://www.nature.com/articles/s41564-018-0218-3.pdf

Reference60 articles.

1. Global Tuberculosis Report 2017 (WHO, 2017); http://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf

2. Gegia, M., Winters, N., Benedetti, A., van Soolingen, D. & Menzies, D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect. Dis. 17, 223–234 (2017).

3. Weis, S. E. et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N. Engl. J. Med. 330, 1179–1184 (1994).

4. Pasipanodya, J. G. & Gumbo, T. A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin. Infect. Dis. 57, 21–31 (2013).

5. Gillespie, S. H. et al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N. Engl. J. Med. 371, 1577–1587 (2014).

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates from a longitudinal study;eLife;2024-09-09

2. Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates from a longitudinal study;eLife;2024-09-09

3. Deciphering Antibiotic-Targeted Metabolic Pathways in Acinetobacter baumannii: Insights from Transcriptomics and Genome-Scale Metabolic Modeling;Life;2024-09-02

4. Association of mutations in Mycobacterium tuberculosis complex (MTBC) respiration chain genes with hyper-transmission;BMC Genomics;2024-08-28

5. Loss of glycerol catabolism confers carbon-source-dependent artemisinin resistance in Mycobacterium tuberculosis;Antimicrobial Agents and Chemotherapy;2024-08-28